The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Immunodeficiency Virus (HIV) Market Research Report 2025
Synopsis
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV).
Report Scope
The Human Immunodeficiency Virus (HIV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunodeficiency Virus (HIV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunodeficiency Virus (HIV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV).
Report Scope
The Human Immunodeficiency Virus (HIV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunodeficiency Virus (HIV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunodeficiency Virus (HIV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV) Market Perspective (2019-2030)
2.2 Human Immunodeficiency Virus (HIV) Growth Trends by Region
2.2.1 Global Human Immunodeficiency Virus (HIV) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Immunodeficiency Virus (HIV) Historic Market Size by Region (2019-2024)
2.2.3 Human Immunodeficiency Virus (HIV) Forecasted Market Size by Region (2025-2030)
2.3 Human Immunodeficiency Virus (HIV) Market Dynamics
2.3.1 Human Immunodeficiency Virus (HIV) Industry Trends
2.3.2 Human Immunodeficiency Virus (HIV) Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV) Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue (2019-2024)
3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2019-2024)
3.2 Global Human Immunodeficiency Virus (HIV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Revenue
3.4 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Revenue in 2023
3.5 Human Immunodeficiency Virus (HIV) Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus (HIV) Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2019-2024)
4.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2025-2030)
5 Human Immunodeficiency Virus (HIV) Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2019-2024)
5.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Market Size (2019-2030)
6.2 North America Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
6.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2019-2030)
7.2 Europe Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
7.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2019-2030)
8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV) Market Size (2019-2030)
9.2 Latin America Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
9.4 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2019-2030)
10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Detail
11.1.2 Gilead Business Overview
11.1.3 Gilead Human Immunodeficiency Virus (HIV) Introduction
11.1.4 Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.1.5 Gilead Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Introduction
11.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Introduction
11.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Human Immunodeficiency Virus (HIV) Introduction
11.4.4 Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.4.5 Merck Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Introduction
11.5.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.5.5 AbbVie Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Introduction
11.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Detail
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Introduction
11.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Human Immunodeficiency Virus (HIV) Introduction
11.8.4 Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.8.5 Genentech Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Human Immunodeficiency Virus (HIV) Introduction
11.9.4 Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2019-2024)
11.9.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
